Lifecore Biomedical, Inc. (LFCR)
Largest Insider Buys in Sector
LFCR Stock Price History Chart
LFCR Stock Performance
About Lifecore Biomedical, Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States and internationally. It operates through Lifecore, Curation Foods, and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology …
Insider Activity of Lifecore Biomedical, Inc.
Over the last 12 months, insiders at Lifecore Biomedical, Inc. have bought $7.2M and sold $0 worth of Lifecore Biomedical, Inc. stock.
On average, over the past 5 years, insiders at Lifecore Biomedical, Inc. have bought $6.1M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Kiper Christopher S () — $6M. WYNNEFIELD PARTNERS SMALL CAP VALUE LP I (10 percent owner) — $4.8M.
The last purchase of 1,463,414 shares for transaction amount of $6M was made by Kiper Christopher S () on 2024‑10‑03.
List of Insider Buy and Sell Transactions, Lifecore Biomedical, Inc.
| 2024-10-03 | 1.46M 2.1987% | $4.10 | $6M | +36.52% | ||||
| 2024-10-03 | 10 percent owner | 292,683 0.4397% | $4.10 | $1.2M | +36.52% | |||
| 2022-11-25 | director | 627,746 1.8334% | $7.97 | $5M | -14.58% |
Insider Historical Profitability
| Kiper Christopher S | 4084268 11.0904% | $7.02 | 1 | 0 | ||
| WYNNEFIELD PARTNERS SMALL CAP VALUE LP I | 10 percent owner | 2607433 7.0802% | $7.02 | 2 | 0 | <0.0001% |